EUVIMED · CrossrefJournal
Disease and Therapeutics
ISSN 3050-9998 · Elsevier BV
Latest articles
Tumor-homing Bispecific Antibodies that Co-engage EPHA2 and Frizzled Receptors Target RNF43-mutant Pancreatic Cancer and Minimize Toxicity
Corrigendum to “Next generation medicines: Emerging approaches to drug ‘difficult to drug’ targets” [Dis. Ther. 3 (2026) 100016]
Corrigendum to “Yeast split intein-mediated protein ligation (ySIMPL) system for detecting protein-protein interactions of mechanosensory proteins” [Dis. Ther. 3 (2026) 100015]
CLIP-LUX: A luminescent split-ubiquitin assay using ClpS-mediated N-degron recognition for detection of protein-protein interactions in mammalian cells
A tetravalent PD-L1/VEGF bispecific antibody blocks tumor growth In Vivo
Psychomotor disturbance as a predictor of treatment response in mood disorders: A systematic review
TBLncDB: A comprehensive lncRNA database for tuberculosis therapeutics and biomarker discovery
Non-small cell lung cancer in 2026: A narrative review of clinical advances and systemic challenges
Chronic and emerging immune-related adverse events from immune checkpoint inhibitors
Next-generation CAR-T combinations: Integrating nanomedicine, metabolic reprogramming, and AI for solid tumor targeting
Postoperative prophylactic corticotropin-releasing hormone receptor 1 (CRHR1) antagonism attenuates post-surgical peritoneal adhesion formation in a rat cecal abrasion model
Yeast split intein-mediated protein ligation (ySIMPL) system for detecting protein-protein interactions of mechanosensory proteins
Next generation medicines: Emerging approaches to drug ‘difficult to drug’ targets
Multi-target mechanisms of ginger constituents against osteoarthritis based on food-medicine homology: An integrative network pharmacology, molecular docking and molecular dynamics study
Translational control as a driver of tumor plasticity, metastasis, and therapeutic resistance in triple-negative breast cancer
Title: A CXCR2-specific monoclonal antibody alleviates excessive neutrophil syndromes in preclinical models of inflammation
Biomimetic internalin B-engineered liposomes enable PROTAC delivery across endothelial barriers
Artificial intelligence in the pharmaceutical research and development lifecycle: Applications, ethical challenges, and governance considerations
Charting a new course in human health: Launching disease and therapeutics
M. tuberculosis meets European lead factory – Identification and structural characterization of novel Rv0183 inhibitors using X-ray crystallography
Projecting the adult vaccine capacity gap in the United States: Forecasting demand and throughput through 2035
ProxiCapture reveals context-dependent CRBN interactome landscape of molecular glue degraders
Disruption of myocardial NAD⁺ balance in heart failure: Mechanisms and therapeutic opportunities
Perturbations at scale: Transforming our understanding of cell biology by changing the genome
KRAS Q61H drives acquired resistance to toceranib through sustained RAS–MAPK signaling in canine mast cell tumor cells
EUVIMED